KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae013 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Fanny Chasseloup und 20 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de …. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Acromegaly, Somatotrophs, Growth Hormone-Secreting Pituitary Adenoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Inserm, AP-HP.
Abstract (Originalsprache)
Importance A paradoxical increase of growth hormone (GH) following oral glucose load has been described in ∼30% of patients with acromegaly and has been related to the ectopic expression of the glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) in somatotropinomas. Recently, we identified germline pathogenic variants and somatic loss of heterozygosity of lysine demethylase 1A (KDM1A) in patients with GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome. The ectopic expression of GIPR in both adrenal and pituitary lesions suggests a common molecular mechanism.
Objective
We aimed to analyze KDM1A gene sequence and KDM1A and GIPR expressions in somatotroph pituitary adenomas. Settings We conducted a cohort study at university hospitals in France and in Italy. We collected pituitary adenoma specimens from acromegalic patients who had undergone pituitary surgery. We performed targeted exome sequencing (gene panel analysis) and array-comparative genomic hybridization on somatic DNA derived from adenomas and performed droplet digital PCR on adenoma samples to quantify KDM1A and GIPR expressions.
Results
One hundred and forty-six patients with sporadic acromegaly were studied; 72.6% presented unsuppressed classical GH response, whereas 27.4% displayed a paradoxical rise in GH after oral glucose load. We did not identify any pathogenic variant in the KDM1A gene in the adenomas of these patients. However, we identified a recurrent 1p deletion encompassing the KDM1A locus in 29 adenomas and observed a higher prevalence of paradoxical GH rise (P = .0166), lower KDM1A expression (4.47 ± 2.49 vs 8.56 ± 5.62, P < .0001), and higher GIPR expression (1.09 ± 0.92 vs 0.43 ± 0.51, P = .0012) in adenomas from patients with KDM1A haploinsufficiency compared with those with 2 KDM1A copies. Conclusions and relevance Unlike in GIP-dependent primary bilateral macronodular adrenal hyperplasia, KDM1A genetic variations are not the cause of GIPR expression in somatotroph pituitary adenomas. Recurrent KDM1A haploinsufficiency, more frequently observed in GIPR-expressing adenomas, could be responsible for decreased KDM1A function resulting in transcriptional derepression on the GIPR locus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse…
- Department of Medicine, Endocrinology Unit, University of Padova, 35128 Padova, Italy.
- AP-HP, Hôpital Antoine Béclère, Université Paris-Saclay, Service d'Histologie, Embryologie et Cytogénomique, 92140 Clamart, France.
- AP-HP, Hôpital Bicêtre, Service de Génétique Moléculaire et d'Hormonologie, 94270 Le Kremlin Bicêtre, France.
- AP-HP, Hôpital Pitié-Salpêtrière, Service de Neurochirurgie, 75013 Paris, France.
- AP-HP, Hôpital Pitié-Salpêtrière, Unité Hypophyse, 75013 Paris, France.
ORCID-Profile: Fanny Chasseloup, Daniela Regazzo, Emmanuelle Kuhn, Mattia Dalle Nogare, Philippe Chanson, Gianluca Occhi, Peter Kamenický
Förderung
- Agence Nationale de la Recherche
- Inserm
- AP-HP
Zitieren
APA
Chasseloup, F., Regazzo, D., Tosca, L., Proust, A., Kuhn, E., Hage, M., Jublanc, C., Mokhtari, K., Dalle Nogare, M., Avallone, S., Ceccato, F., Tachdjian, G., Salenave, S., Young, J., Gaillard, S., Parker, F., Boch, A. L., Chanson, P., Bouligand, J., …, & Kamenický, P. (2024). KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae013
Vancouver
Chasseloup F, Regazzo D, Tosca L, Proust A, Kuhn E, Hage M, et al. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae013
BibTeX
@article{Chasseloup2024,
author = {Chasseloup, Fanny and Regazzo, Daniela and Tosca, Lucie and Proust, Alexis and Kuhn, Emmanuelle and Hage, Mirella and Jublanc, Christel and Mokhtari, Karima and Dalle Nogare, Mattia and Avallone, Serena and Ceccato, Filippo and Tachdjian, Gerard and Salenave, Sylvie and Young, Jacques and Gaillard, Stephan and Parker, Fabrice and Boch, Anne-Laure and Chanson, Philippe and Bouligand, Jerome and Occhi, Gianluca and Kamenický, Peter},
title = {KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae013}
}
EUVIMED